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Echocardiography Contrast for Image Optimization:
Beyond Conﬁdence, It Is a Matter of Accuracy*
Patricia A. Pellikka, MD, FACC, Sharon L. Mulvagh, MD, FACC
Rochester, MinnesotaSince the first intravenously administered echocar-
diographic contrast agent capable of left ventricular
cavity opacification to enhance visualization of the
endocardium was approved by the Food and Drug
Administration (FDA) more than 13 years ago,
important advances in these agents and in the
ultrasound equipment permitting their detection
have occurred.
See page 145
Current agents not only scatter and reflect, but
also interact with administered ultrasound through
harmonic and multipulse sequencing to increase
signal intensity over background tissue noise. Mod-
ifications in the agents, along with these unique
methods of ultrasound delivery and reception, have
resulted in robust and persistent contrast effect.
There has been wide clinical acceptance of contrast
agents for the application of improving echocardio-
graphic imaging in patients for whom initial trans-
thoracic images are technically suboptimal. Admin-
istration of these agents in a busy clinical practice
has been shown to be efficient and cost-effective (1).
Accurate visualization of endocardial borders is
of crucial importance in stress echocardiography, as
this technique involves assessment of global and
segmental wall thickening and motion (2). In this
test, the endocardial border must be assessed
quickly and in multiple planes. Not surprisingly,
this has become the area of echocardiography in
which contrast agents are most frequently used.
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the view of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
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Plana et al. (3) report new evidence that contrast
agents increased the accuracy of dobutamine stress
echocardiography for detection of angiographic cor-
onary artery disease. In this prospective study, 101
patients underwent, in randomized order, 2 dobut-
amine stress tests performed at least 4 h but no
more than 24 h apart, 1 with and 1 without a
contrast agent. Harmonic imaging was used for all
studies, and ultrasound settings were optimized for
endocardial border detection. Echocardiograms
were reviewed by a single observer who was blinded
to other data. In the 92 patients who underwent
coronary angiography, accurate detection of isch-
emia, represented as new or worsening regional wall
motion abnormality, corresponding to angiographic
stenosis 70% narrowing of the lumen diameter
was significantly higher with contrast agents than
without. Not surprisingly, the impact of contrast
agents on accuracy was greatest in studies in which
confidence of interpretation of regional wall motion
was low without contrast agents. In this subgroup,
accuracy increased from 36% to 68% (p  0.01).
Plana et al. (3) found that contrast agents in-
creased endocardial visualization at rest and during
stress and increased the confidence of interpretation
of the studies. This confirms the previous observa-
tions of Rainbird et al. (4), in which 300 consecu-
tive patients underwent contrast dobutamine stress
echocardiography; images were interpreted with
and without the use of intravenous contrast agents.
In this study, the percentage of wall segments
visualized at rest increased from 96.4  9.6% to
99.7  2.5% (p  0.01) with the addition of
contrast agents and at peak stress from 94.4 
13.7% to 99.8  1.5% (p  0.01). Similarly, the
confidence of interpretation was superior with con-
trast imaging compared with noncontrast imaging
both at rest (p 0.01) and at peak stress (p 0.01).
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154lthough the confidence of interpretation declined
n the comparison of rest to peak stress images, this
id not occur when contrast agents were adminis-
ered. Although all image quality subgroups bene-
ted from the use of contrast agents, those with the
oorest quality images benefited the most (4).
hy Has It Taken So Long to
emonstrate That Contrast Agents Improve
ccuracy of Stress Echocardiography?
irst, the effect of contrast agents on accuracy could
ot be demonstrated without referral of sufficient
umbers of patients for coronary angiography. Sec-
nd, it was also necessary that a sufficient number of
oncontrast agent studies be of suboptimal quality;
t is in this situation that contrast agents provide the
reatest benefit. In the study by Rainbird et al. (4),
n which noncontrast image quality was generally
ood, only 35 patients underwent coronary angiog-
aphy. In this small subgroup, no benefit of contrast
gents on the accuracy of stress echocardiography
ould be demonstrated. The current study was
ogistically challenging, as 2 dobutamine stress
chocardiograms, with and without a contrast
gent, were performed in each patient. Further-
ore, 91% of patients underwent coronary angiog-
aphy. The investigators are to be congratulated on
ndertaking and completing this ambitious study.
n Which Patients Undergoing Stress
chocardiography Should Contrast Agents
or LV Cavity Opaciﬁcation Be Used?
he American Society of Echocardiography recom-
ends that contrast agents be used when 2 or more
ndocardial segments cannot be adequately visual-
zed (2). These guidelines are reasonable and ap-
ropriate. In the current study, the accuracy for
etection of ischemia was significantly higher only
or circumflex lesions (p  0.0009), probably be-
ause of technical difficulties in visualizing the
ateral wall and the smaller amount of myocardium
ubtended by this vessel. Importantly, there was no
mpact attributed to contrast agents in studies
nterpreted with high confidence. Contrast agents
ncrease the expense of performing a stress echocar-
iogram and are not necessary in the majority of
atients, that is, those in whom assessment of
egional wall motion is feasible without contrast
gents. tre Contrast Agents Safe?
he FDA has recently issued a black box warning
bout the safety of echocardiography contrast
gents. This warning was issued on the basis of
ost-marketing reports of deaths that were tempo-
ally related to contrast agent use in 4 patients with
ignificant underlying progressive cardiovascular
isease and approximately 190 other variably char-
cterized nonfatal adverse events, without conclu-
ive evidence of causality. These events occurred
ver a 6-year period during which approximately 2
illion patient doses of contrast agents were ad-
inistered, for a mortality rate of approximately 1
n 500,000. Indeed, most large echocardiography
aboratories have used these agents in hundreds or
housands of patients, especially for stress echocar-
iography, without any fatalities. Occasional intol-
rance and rare allergic reactions (estimated rate 1
n 10,000) have been noted. Because stress echo-
ardiography involves the study of patients who are
n sufficiently stable condition to withstand stress
esting and because monitoring of the electrocar-
iogram and vital signs is a standard part of the test,
ontrast agents for endocardial border detection can
ontinue to be safely performed in these patients; that
s the practice at the Mayo Clinic. We continue to use
sonographer-driven decision-making algorithm for
ontrast agent use with screening for safety performed
y our trained registered nurses, who are cognizant of
he new contraindications in the revised package
nsert, and continue to obtain verbal consent from the
atient before administration.
Current interest in echocardiography contrast
echnique has focused on myocardial perfusion and
ombinations of perfusion images with regional
all motion assessment during stress echocardiog-
aphy, as can be achieved with off-label use of
xisting contrast agents. Ultrasound settings for
ppreciating myocardial contrast involve the use of
combination of high and low mechanical index
ettings. Investigators have shown that inducible
erfusion abnormalities seen with myocardial con-
rast echocardiography may occur before regional
all motion abnormalities and that myocardial
erfusion imaging during dobutamine stress echo-
ardiography provides incremental prognostic in-
ormation in patients with known or suspected
oronary artery disease (5,6). In fact, initial findings
ave suggested that quantitative assessment of the
ystolic to diastolic ratio of arteriolar blood volume
ight be used to detect coronary stenosis withouthe need for a stress test (7). However, although
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155nique agents are currently undergoing the rigors of
DA evaluation, there is not yet an approved echo
ontrast agent for myocardial perfusion imaging.
In conclusion, contrast agent use during stress
chocardiography has been clearly demonstrated to
mprove visualization of endocardial border seg-
ents and confidence of test interpretation in
atients for whom noncontrast images are subopti-
al. Plana et al. (3) have confirmed the logical
xtension of this observation: if you can better see
he structures required for interpretation of the
tudy results, test performance will be more accu-al. A randomized cross-over study for imaging and wallimultaneous detection of left ventricular cavity
pacification and myocardial perfusion. Further
tudies in large numbers of patients are needed to
stablish the incremental role of contrast agents,
hen combined with perfusion assessments, for
valuating the patient with known or suspected
oronary artery disease.
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